Exelixis Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Deciphera Pharmaceuticals.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alameda, US HQ | Locations Waltham, US HQ Lawrence, US |
Employees | Employees 1,14712% decrease | Employees 35037% increase |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 2.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $163.4m (FY, 2023) |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $3.7m (FY, 2023) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit $159.6m (FY, 2023) |
Net income | Net income $782.6m (FY, 2025) | Net income ($194.9m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company